Literature DB >> 31957700

IL-10 induces TGF-β secretion, TGF-β receptor II upregulation, and IgA secretion in B cells.

Yasser Bagheri1,2, Fateme Babaha1, Reza Falak2, Reza Yazdani3, Gholamreza Azizi4, Maryam Sadri5, Hassan Abolhassani6, Mehdi Shekarabi2, Asghar Aghamohammadi3.   

Abstract

Interleukin-10 (IL-10) is a pleiotropic cytokine, which has both regulatory and stimulatory effects on different immune cell types. Different studies have reported the importance of IL-10 and Transforming growth factor-beta (TGF-β) in the regulation of B cell class switching the production of immunoglobulin A (IgA); however, the underlying mechanisms remain to be fully elucidated. The objective of this study was to investigate the TGF-β response during B stimulation of human B cells by IL-10. Pan B cells of healthy donors were negatively purified by a magnetic cell separation technique. B cells were cultured with multimeric CD40 ligand (mCD40L) and IL-10 for two and seven days. After harvesting in specific days, TGF-β receptor II and surface IgA expression was determined by flow cytometry, while IgA and TGF-β secretion was assessed by enzyme-linked immunosorbent assay. B cells endogenously expressed TGF-β receptor II and after 48 hours cultivation with mCD40L or mCD40L plus IL-10, both the expression of this receptor and the production of TGF-β were significantly increased. Notably, TGF-β levels following stimulation with mCD40L and IL-10 were higher than those produced by B cells stimulated with mCD40L alone. Furthermore, at day 7 and following IL-10 stimulation, there was a significant rise in the amount of IgA secretion by class-switched plasma cells, which was higher than stimulation with mCD40L alone. Our findings suggest that IL-10 can modulate TGF-β production and TGF-β receptor expression in mCD40-activated human B lymphocytes.

Entities:  

Keywords:  class switching; immunoglobulin A; interleukin-10; transforming growth factor-β

Mesh:

Substances:

Year:  2019        PMID: 31957700     DOI: 10.1684/ecn.2019.0434

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  6 in total

1.  Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.

Authors:  Lia Furlaneto Marega; Janine Schincariol Sabino; Marcus Vinicius Pedroni; Marcelo Teocchi; Carolina Lanaro; Dulcinéia Martins de Albuquerque; Irene Pereira Dos Santos; Fernando Ferreira Costa; Maria Marluce Dos Santos Vilela
Journal:  Immunol Res       Date:  2021-08-14       Impact factor: 2.829

Review 2.  Cytokine Signature and Involvement in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Florent Carsuzaa; Émilie Béquignon; Xavier Dufour; Guillaume de Bonnecaze; Jean-Claude Lecron; Laure Favot
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

3.  Elevated IgA and IL-10 levels in very-early-onset inflammatory bowel disease secondary to IL-10 receptor deficiency.

Authors:  Natascha Silva Sandy; Lia Furlaneto Marega; Giane Dantas Bechara; Adriana Gut Lopes Riccetto; Carmen Bonfim; Maria Marluce Dos Santos Vilela; Antonio Fernando Ribeiro; Maria De Fatima Servidoni; Elizete Aparecida Lomazi
Journal:  Rev Paul Pediatr       Date:  2021-10-29

4.  Lacticaseibacillus rhamnosus modulates the inflammatory response and the subsequent lung damage in a murine model of acute lung inflammation.

Authors:  Fabiana Olimpio; José Roberto Mateus da Silva; Rodolfo P Vieira; Carlos R Oliveira; Flavio Aimbire
Journal:  Clinics (Sao Paulo)       Date:  2022-03-15       Impact factor: 2.365

Review 5.  Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors.

Authors:  Lin Zhang; Chao Zhou; Songou Zhang; Xiaozhen Chen; Jian Liu; Fangming Xu; Wenqing Liang
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

Review 6.  B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments.

Authors:  Yuan Wei; Chun-Xiang Huang; Xiao Xiao; Dong-Ping Chen; Hong Shan; Huanhuan He; Dong-Ming Kuang
Journal:  Oncogene       Date:  2021-06-29       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.